HSA-IFNa2b
- 产品详情
- 实验流程
Species | Human |
---|---|
Purity | Greater than 98.0% as determined by: (a) Analysis by RP-HPLC (b) Anion-exchange FPLC (c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel |
Endotoxin Level | Less than 0.1 ng/ µg (1 EU/ µg) of human HSA-IFN-α 2b |
Formulation | Lyophilized from a (1 mg/ml) solution in containing 5.55 mg sodium phosphate dibasic, 5.55 mg sodium phosphate monobasic buffer, 296 mg sucrose and 0.37 mg Tween 80. |
Reconstitution | It is recommended to reconstitute the lyophilized HSA-IFN a2b in sterile 18 MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. |
Target Background | At least 23 different variants of Interferon-alpha are known. The individual proteins have molecular masses between 19,000-26,000 Da and consist of proteins with lengths of 156-166 and 172 amino acids. All IFN-alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN-alpha subtypes differ in their sequences at only one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxyl-terminal end. Human Serum Albumin and Interferon (HSA-IFN)-α 2b produced in P. Pichia is a single non-glicosylated, polypeptide chain having a molecular mass of 85,700 Da. |
---|
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.